P. Rowley

发表

Textural differences between AA and SS blood specimens as detected by image analysis.

R. D. Robinson, L. Benjamin, J. Cosgriff, 1994, Cytometry.

The neurofibroma in von Recklinghausen neurofibromatosis has a unicellular origin.

P. Rowley, G. Skuse, B. Kosciolek, 1991, American journal of human genetics.

Mechanism of action of transaldolase.

P. Rowley, C. Lai, B. Horecker, 1962, Federation proceedings.

Induction of the fms proto-oncogene product in HL-60 cells by vitamin D: a flow cytometric analysis.

P. Rowley, J. Leary, B. Farley, 1992, Leukemia research.

Oncogene expression in myelopoiesis.

P. Rowley, G. Skuse, 1987, International journal of cell cloning.

Circular Antisense Oligonucleotides Inhibit Growth of Chronic Myeloid Leukemia Cells

P. Rowley, E. Kool, B. Kosciolek, 1999, Molecular medicine.

The effect of bcr-abl antisense oligonucleotide on DNA synthesis and apoptosis in K562 chronic myeloid leukemia cells.

P. Rowley, P. Keng, B. Kosciolek, 1996, Leukemia research.

Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: effects on knowledge and mood.

P. Rowley, M. Lipkin, L. Fisher, 1979, American journal of human genetics.

Separation of malarial parasites according to age by density gradient centrifugation.

P. Rowley, W. A. Siddiqui, Q. M. Geiman, 1967, The Journal of laboratory and clinical medicine.

Cystic fibrosis carrier population screening in the primary care setting.

S. Loader, P. Rowley, J. Levenkron, 1996, American journal of human genetics.

Prenatal genetic counseling for hemoglobinopathy carriers: a comparison of primary providers of prenatal care and professional genetic counselors.

S. Loader, P. Rowley, A. Kozyra, 1995, American journal of human genetics.

Oncogene Expression in Neurofibromatosis a

P. Rowley, B. Kosciolek, J. Bader, 1986, Annals of the New York Academy of Sciences.

Induction of HL60 cell differentiation by tiazofurin and its analogues: characterization and efficacy.

P. Rowley, J. Leary, V. Marquez, 1991, Blood.

Impact of genetic counseling and DNA testing on individuals with colorectal cancer with a positive family history: a population-based study.

S. Loader, P. Rowley, C. Shields, 2005, Genetic testing.

Issues in implementing prenatal screening for cystic fibrosis: Results of a working conference

K. Klinger, P. Rowley, W. Grody, 1999, Genetics in Medicine.

Deleterious mutations of both BRCA1 and BRCA2 in three siblings.

S. Loader, P. Rowley, Peter T. Rowley, 1998, Genetic testing.

K562 human erythroleukemia cell variants resistant to growth inhibition by butyrate have deficient histone acetylation.

P. Rowley, B. Ohlsson-Wilhelm, B. Kosciolek, 1984, American journal of human genetics.

Familial growth retardation, renal aminoaciduria and cor pulmonale. I. Description of a new syndrome, with case reports.

P. Rowley, P. Mueller, L. Rosenberg, 1961, The American journal of medicine.

Induction of megakaryocytic characteristics in human leukemic cell line K562: polyploidy, inducers, and secretion of mitogenic activity.

P. Rowley, B. Kosciolek, J. Leary, 1987, Journal of biological regulators and homeostatic agents.

Linkage Between the MN- and Hb β-Loci?

P. Rowley, L. Weitkamp, M. S. Adams, 1972 .

Attitudes of Obstetrician‐Gynecologists Toward DNA Testing for a Genetic Susceptibility to Breast Cancer

S. Loader, P. Rowley, 1996, Obstetrics and gynecology.

Pathogenesis of deficient serum α1-antitrypsin in the type ZZ homozygote

P. Rowley, R. Schwartz, M. L. Sevilla, 1974, Biochemical Genetics.

Do Pregnant Women Benefit from Hemoglobinopathy Carrier Detection?

S. Loader, P. Rowley, M. Walden, 1989, Annals of the New York Academy of Sciences.

Capping of bcr-abl antisense oligonucleotides enhances antiproliferative activity against chronic myeloid leukemia cell lines.

P. Rowley, B. Kosciolek, M. Thomas, 1994, Leukemia research.

The diagnosis of beta‐thalassemia trait: A review

P. Rowley, 1976, American journal of hematology.

Regulation of K562 cell transferrin receptors by exogenous iron

P. Rowley, B. Ohlsson-Wilhelm, J. Leary, 1985, Journal of cellular physiology.

Development of telomerase inhibitors

P. Rowley, 2001 .

Single-cell analysis of the relationship among transferrin receptors, proliferation, and cell cycle phase in K562 cells.

P. Rowley, B. Ohlsson-Wilhelm, J. Leary, 1985, Cytometry.

Telomerase: putting an end to DNA.

P. Rowley, 1998, Cancer investigation.

THE MECHANISM OF ACTION OF ADLOLASES. V. INACTIVATION OF FLUORO- AND CHLORODINITROBENZENE.

P. Rowley, B. Horecker, O. Tchola, 1964, Archives of biochemistry and biophysics.

Psychological aspects of genetic counseling

P. Rowley, 1986 .

P. Rowley, B. Kosciolek, 1999, Leukemia research.

Prenatal screening for hemoglobinopathies. I. A prospective regional trial.

S. Loader, P. Rowley, M. Walden, 1991, American journal of human genetics.

Prenatal screening for hemoglobinopathies. II. Evaluation of counseling.

S. Loader, P. Rowley, M. Walden, 1991, American journal of human genetics.

Prenatal screening for hemoglobinopathies. III. Applicability of the health belief model.

S. Loader, P. Rowley, M. Walden, 1991, American journal of human genetics.

Pregnant women identified as hemoglobinopathy carriers by prenatal screening want genetic counseling and use information provided.

S. Loader, P. Rowley, M. Walden, 1988, Birth defects original article series.

Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: comparison of three counseling methods.

P. Rowley, M. Lipkin, L. Fisher, 1984, American journal of human genetics.

Genetic counseling for beta-thalassemia trait following health screening in a health maintenance organization: comparison of programmed and conventional counseling.

P. Rowley, M. Lipkin, L. Fisher, 1981, American journal of human genetics.

Genetic discrimination: rights and responsibilities of tester and testee: summary of a workshop sponsored by the Social Issues Committee, American Society of Human Genetics, November 2, 1986.

P. Rowley, 1988, American journal of human genetics.

Regulation of the activity of heme degradative enzymes in K562 erythroleukemic cells: induction by thymidine.

P. Rowley, M. Maines, G. Trakshel, 1987, Experimental hematology.

Hemin preferentially stimulates synthesis of alpha-globin in K562 human erythroleukemia cells

P. Rowley, S. Labella, N. Rudolph, 1982 .

Hemin preferentially stimulates synthesis of alpha-globin in K562 human erythroleukemia cells.

P. Rowley, B. Ohlsson-Wilhelm, B. Kosciolek, 1982, Blood.

Familial hearing loss associated with branchial fistulas.

P. Rowley, 1969, Pediatrics.

Characteristics of the antitrypsin activity of human serum

P. Rowley, D. Oette, 1973, Journal of clinical pathology.

Serum Antitrypsin Synthesis by the Isolated Perfused Rat Liver

P. Rowley, L. L. Miller, 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Newborn screening for hemoglobinopathies in New York State: experience of physicians and parents of affected children.

P. Rowley, N. S. Warren, J. Humbert, 1982, The Journal of pediatrics.

The linkage relationships of the haemoglobin beta, delta and alpha loci with 34 genetic marker systems

P. Rowley, G. Stamatoyannopoulos, R. Kirk, 1977, Annals of human genetics.

Human lymphocyte telomerase is genetically regulated

P. Rowley, B. Kosciolek, 1998, Genes, chromosomes & cancer.

Thalassemia: Pathophysiology and management. Part A

P. Rowley, S. Fucharoen, N. W. Paul, 1988 .

The mechanism of action of aldolases. III. Schiff base formation with lysine.

P. Rowley, B. Horecker, T. Cheng, 1962, Biochemical and biophysical research communications.

Identity of Synthetic N6-β-Glyceryllysine and the C14-Labeled Amino Acid Obtained on Sodium Borohydride Reduction and Hydrolysis of a Complex from C14-Fructose 6-Phosphate-Transaldolase Interaction

P. Rowley, J. C. Speck, B. Horecker, 1963 .

TRIPLOID CELLS IN A HUMAN EMBRYO

P. Rowley, J. Delhanty, J. R. Ellis, 1961 .

Gaucher disease. Current issues in diagnosis and treatment. NIH Technology Assessment Panel on Gaucher Disease.

W. H. Hall, Robin E Berman, F. Collins, 1996, JAMA.

A genetical and cytological study of repeated spontaneous abortion

P. Rowley, J. R. Ellis, R. Marshall, 1963, Annals of human genetics.

High resolution analysis of hemoglobins: polyacrylamide isoelectric focusing.

P. Rowley, R. Doherty, L. Weitkamp, 1972, Biochemical medicine.

Sickle β‐thalassemia: Identical twins differing in severity implicate nongenetic factors influencing course

P. Rowley, P. Griner, S. Joishy, 1976, American journal of hematology.

Sickle hemoglobin: a specific radioimmunoassay.

P. Rowley, R. Doherty, E. Cernichiari, 1974, Blood.

Multipotent human hematopoietic cell line K562: lineage-specific constitutive and inducible antigens.

P. Rowley, B. Ohlsson-Wilhelm, J. Leary, 1987, Leukemia research.

Inducers of erythroid differentiation in K562 human leukemia cells.

P. Rowley, B. Ohlsson-Wilhelm, S. Labella, 1981, Experimental hematology.

Hemoglobin synthesis in cultures of hepatic erythroid cells from the human fetus.

P. Rowley, B. Ohlsson-Wilhelm, B. Kosciolek, 1979, Proceedings of the National Academy of Sciences of the United States of America.

Protein Synthesis in Reticulocytes Maturing IN VIVO

P. Rowley, 1965, Nature.

An adult homozygous for persistent fetal hemoglobin.

P. Rowley, W. Schroeder, W. Siegel, 1970, Annals of internal medicine.

Erythroleukemia Manifesting δβ-Thalassemia

P. Rowley, K. Goh, R. Markham, 1983 .

Genetic counseling of asymptomatic carriers in a primary care setting. The effectiveness of screening and counseling for beta-thalassemia trait.

S. Loader, P. Rowley, M. Lipkin, 1986, Annals of internal medicine.

Induction of -globin synthesis in the -thalassaemia of Ferrara.

P. Rowley, L. del Senno, S. Pontremoli, 1972, Nature: New biology.

Erythroid colony formation from human fetal liver.

P. Rowley, B. Ohlsson-Wilhelm, B. Farley, 1978, Proceedings of the National Academy of Sciences of the United States of America.

Anhidrotic ectodermal dysplasia: predisposition to bronchial disease.

P. Rowley, J. Lindgren, R. Rosan, 1971, Annals of internal medicine.

Inhibition of telomerase activity in human cancer cells by RNA interference.

P. Rowley, K. Kalantidis, B. Kosciolek, 2003, Molecular cancer therapeutics.

Tumor-Suppressor Genes and Human Neoplasia

P. Rowley, G. Skuse, 1991 .

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.

S. Cummings, S. Loader, P. Rowley, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular genetic analysis of tumors in von recklinghausen neurofibromatosis: Loss of heterozygosity for chromosome 17

P. Rowley, G. Skuse, B. Kosciolek, 1989, Genes, chromosomes & cancer.

Impact of genetic testing for breast-ovarian cancer susceptibility.

S. Loader, P. Rowley, C. Shields, 2004, Genetic testing.

Genetic testing for breast-ovarian cancer susceptibility: a regional trial.

S. Loader, P. Rowley, J. Levenkron, 1998, Genetic testing.

Acquired hemoglobin H disease in idiopathic myelofibrosis

P. Rowley, B. Kosciolek, A. Bauman, 1979, American journal of hematology.

Newborn sickle cell screening. Benefits and burdens realized.

P. Rowley, D. Huntzinger, 1983, American journal of diseases of children.

Sickle cell trait/hereditary persistence of fetal hemoglobin trait. Misdiagnosis as sickle cell anemia by newborn screening.

P. Rowley, E. Rubin, 1979, A M A Journal of Diseases of Children.

Newborn screening for sicle-cell disease. Benefits and burdens.

P. Rowley, 1978, New York state journal of medicine.

Studies in familial periodic paralysis

P. Rowley, A. Engel, G. Shy, 1961 .

The effect of sodium loading and depletion on muscular strength and aldosterone excretion in familial periodic paralysis.

P. Rowley, B. Kliman, 1960, The American journal of medicine.

Patient vs. physician as the target of educational outreach about screening for an inherited susceptibility to colorectal cancer.

S. Loader, P. Rowley, C. Shields, 2002, Genetic testing.

Carrier screening for cystic fibrosis: test acceptance and one year follow-up.

S. Loader, P. Rowley, J. Levenkron, 1997, American journal of medical genetics.

K562 cell erythroid differentiation: requirement for a factor in fetal bovine serum.

P. Rowley, B. Ohlsson-Wilhelm, B. Kosciolek, 1985, Experimental hematology.

Erythropoiesis in vitro: enhancement by neuraminidase.

P. Rowley, B. Ohlsson-Wilhelm, B. Farley, 1981, Blood.

Cystic fibrosis carrier screening: knowledge and attitudes of prenatal care providers.

S. Loader, P. Rowley, J. Levenkron, 1993, American journal of preventive medicine.

A Lepore hemoglobin in a Rumanian family.

P. Rowley, E. Williams, F. Barnes, 1969, Human heredity.

Protein synthesis in the maturing reticulocyte.

P. Rowley, J. Morris, 1967, The Journal of biological chemistry.

Trypsin enhances erythropoiesis in vitro.

P. Rowley, B. Ohlsson-Wilhelm, B. Kosciolek, 1980, The Journal of laboratory and clinical medicine.

Disappearance of Ribosomes and Polyribosomes during in vivo Erythroid Maturation

P. Rowley, 1967, Nature.

Monozygotic twins concordant for Huntington's chorea

P. Rowley, N. Myrianthopoulos, Ntinos C. Myrianthopoulos, 1960, Neurology.

Single K562 human leukemia cells express and are inducible for both erythroid and megakaryocytic antigens.

P. Rowley, J. Leary, R. Giuliano, 1992, International journal of cell cloning.

Genetic screening: marvel or menace?

P. Rowley, 1984, Science.

Prenatal screening for cystic fibrosis carriers: an economic evaluation.

S. Loader, P. Rowley, R. Kaplan, 1998, American journal of human genetics.

Inherited susceptibility to colorectal cancer.

P. Rowley, 2005, Annual review of medicine.

K562 human leukemia cell passages differ in embryonic globin gene expression.

P. Rowley, B. Ohlsson-Wilhelm, C. Lozzio, 1984, Leukemia research.

Induction of hemoglobin synthesis in K562 cells by carbon dioxide deficiency.

P. Rowley, B. Ohlsson-Wilhelm, B. Farley, 1987, International journal of cell cloning.

Solubilization of a reticulocyte ribosomal fraction responsible for the decline in ribosomal activity with cell maturation.

P. Rowley, M. H. Adams, R. A. Midthun, 1971, Archives of biochemistry and biophysics.

Tetrahydrocannabinol inhibits adenyl cyclase in human leukemia cells.

P. Rowley, J. Rowley, 1990, Life sciences.

Erythroid induction of K562 human leukemia cells: enhancement by purines.

P. Rowley, B. Ohlsson-Wilhelm, N. Rudolph, 1985, Archives of biochemistry and biophysics.

Human Erythroleukemia Cells Demonstrate Commitment

P. Rowley, B. Ohlsson-Wilhelm, B. Farley, 2005 .

K562 human erythroleukemia cells demonstrate commitment.

P. Rowley, B. Ohlsson-Wilhelm, B. Farley, 1985, Blood.

Alveolar cell carcinoma in identical twins. Similarity in time of onset, histochemistry, and site of metastasis.

P. Rowley, S. Joishy, R. Cooper, 1977, Annals of internal medicine.

Hereditary haemorrhagic telangiectasia: aggravation by oral contraceptives?

P. Rowley, J. Kurnick, R. Cheville, 1970, Lancet.

Identifying genetic factors affecting music ability.

P. Rowley, Peter T. Rowley, 1988 .

Cystic fibrosis newborn screening: a pilot study to maximize carrier screening.

P. Rowley, G. Arnold, S. Labella, 2005, Genetic testing.

Prenatal Diagnosis for Sickle Cell Disease a

P. Rowley, 1989 .

Prenatal hemoglobinopathy screening. IV. Follow-up of women at risk for a child with a clinically significant hemoglobinopathy.

S. Loader, P. Rowley, A. Kozyra, 1991, American journal of human genetics.

Hemoglobin S-C disease presenting as acute cor pulmonale.

P. Rowley, D. Enlander, 1968, The American review of respiratory disease.

Women's receptivity to testing for a genetic susceptibility to breast cancer.

W J Hall, S. Loader, P. Rowley, 1995, American journal of public health.

Screening for an inherited susceptibility to colorectal cancer.

P. Rowley, 2004, Genetic testing.

Reproductive pasts, reproductive futures: Genetic counseling and its effectiveness

P. Rowley, 1984 .

Prenatal screening for hemoglobinopathies.

P. Rowley, 1991, American Journal of Human Genetics.

THE MECHANISM OF ACTION OF ALDOLASES. IV. LYSINE AS THE SUBSTRATE-BINDING SITE.

P. Rowley, B. Horecker, T. Cheng, 1963, Biochemische Zeitschrift.

Assessment of Evaluation of Hospitalized Pediatric Patients with Genetic Disorders

P. Rowley, M. Lessick, A. Vanputte, 1981, Clinical pediatrics.

Genetic Responsibility

P. Rowley, M. Lipkin, 1974, Springer US.

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

K Offit, A Oliphant, S. Loader, 1997, JAMA.

Statement from the National Institutes of Health workshop on population screening for the cystic fibrosis gene.

K. Klinger, N. Holtzman, F. Collins, 1990, The New England journal of medicine.

Prenatal hemoglobinopathy screening: receptivity of Southeast Asian refugees.

S. Loader, P. Rowley, M. Walden, 1987, American journal of preventive medicine.

Prenatal diagnosis for sickle cell disease. A survey of the United States and Canada.

P. Rowley, 1989, Annals of the New York Academy of Sciences.

Inhibition of telomerase activity in human cancer cells by RNA interference.

P. Rowley, K. Kalantidis, B. Kosciolek, 2003, Molecular cancer therapeutics.

The mechanism of action of aldolases

P. Rowley, B. Horecker, O. Tchola, 1964 .

Gaucher disease: Current issues in diagnosis and treatment

W. H. Hall, Robin E Berman, F. Collins, 1996 .

Enhanced polyribosome recovery from reticulocytes using heparin.

P. Rowley, J. Morris, 1967, Experimental Cell Research.

Cystic fibrosis carrier population screening: a review.

S. Loader, P. Rowley, J. Levenkron, 1997, Genetic testing.